Clinical Trials Arena October 28, 2024
Motivated patients with rare diseases are using social media widely, making it an effective way to reach patients for trial recruitment.
Social media has become an excellent tool for targeting specific patients for clinical trials, says Chris Adams, the CEO at Andarix Pharmaceuticals, a biotech developing targeted oncology therapies.
Adams was speaking at the Outsourcing in Clinical Trials conference in Boston, New England, being held 23 – 24 October, where experts discussed challenges and strategies surrounding clinical trial operations.
Adams spoke about how Andarix is using a software called PRISM to use social media to target specific individuals with rare diseases. Social media can help overcome challenges related to patient geographic dispersal, and raises awareness of the trial, said Adams....
Today's Sponsors
Today's Sponsor